Journals / Tüberküloz ve Toraks / 2012 / Cilt: 60 - Sayı: 4

Interstitial lung disease associated with connective tissue diseases: diagnosis and treatment approaches

Bağ dokusu hastalıklarına bağlı gelişen interstisyel akciğer hastalığı: Tanı ve tedavi yaklaşımları

Pages
393–400
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Interstitial lung disease constitute an important group in this respect and it is estimated that the overall incidence of 15%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Connective tissue diseases are a diverse group of immunologically mediated systemic disorders that often lead to thoracic changes.
📊
Key Findings & Data:However, increased mortality and morbidity develops pulmonary involvement due to connective tissue diseases.
💡
Conclusion & Impact:Interstitial lung disease constitute an important group in this respect and it is estimated that the overall incidence of 15%.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Connective tissue diseases are a diverse group of immunologically mediated systemic disorders that often lead to thoracic changes. There are huge differences between epidemiological studies depending upon method of ascertainment and selec tion criteria regarding the incidence of respiratory involvement due to connective tissue diseases. However, increased mortality and morbidity develops pulmonary involvement due to connective tissue diseases. Interstitial lung disease constitute an important group in this respect and it is estimated that the overall incidence of 15%. Today, still diagnosis, treatment, follow-up, prognosis of IInterstitial lung disease due to Connective tissue diseases (CTD-ILD) related clinical problems have been experienced. The diagnostic methods of disease include clinical approach, pulmonary function tests, high-resolution computed tomography, bronchoalveolar lavage and surgical lung biopsy. Treatment and selection of drugs are still controversial. In this review, a CTD-ILD, separately for each diagnosis, pulmonary function tests and radiological features, prognosis and treatment approaches were evaluated.

Özet

Bağ dokusu hastalıkları sıklıkla torasik değişikliklere yol açan immünolojik aracılı bir grup sistemik hastalıktır. Bağ dokusu hastalıklarında solunum sistemi tutulumu sıklığı ile ilgili yapılan epidemiyolojik çalışmalar arasında tespit ve seçilme yöntemlerine bağlı büyük farklılıklar vardır. Ancak bağ dokusu hastalıklarında pulmoner tutulum geliştiğinde mortalite ve morbidite artmaktadır. İnterstisyel akciğer hastalığı, bu anlamda önemli bir grubu oluşturmakta ve genel insidansın %15 olduğu tahmin edilmektedir. Günümüzde halen bağ dokusu hastalıklarına bağlı interstisyel akciğer hastalığının tanı, tedavi, takip ve prognozu ile ilgili klinik sorunlar yaşanmaktadır. Hastalığın tanısal yöntemleri klinik yaklaşım, solunum fonksiyon testleri, yüksek çözünürlüklü bilgisayarlı tomografi, bronkoalveoler lavaj ve cerrahi akciğer biyopsisini içermektedir. Tedavi ve ilaç seçiminde tartışmalar devam etmektedir. Bu derlemede her bir bağ dokusu hastalığı için ayrı ayrı tanı, solunum fonksiyon testi ve radyolojik özellikler, prognoz ve tedavi yaklaşımlarının değerlendirilmesi amaçlanmıştır.

🔖

Cite This Article

PAMUK, Ö. N., KURT, B., KAR, Ö. K. (2022). Interstitial lung disease associated with connective tissue diseases: diagnosis and treatment approaches. Tüberküloz ve Toraks, Cilt: 60 - Sayı: 4, 393–400. https://ajindex.com/articles/618711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177: 1248-54
  2. Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, König G, et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 1996; 154: 400-6
  3. Goh NSL, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosisassociated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007; 56: 2005-12
  4. American Thoracic Society/European Respiratory and Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2002; 165: 277-304
  5. Lee H, Kim DS, Yoo B, Seo JB, Rho J, Colby TV, et al. Histopathologic pattern and clinical features of rheumatoid arthritisassociated interstitial lung disease. Chest 2005; 127: 2019-27
  6. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004; 232: 81-91
  7. Renzoni E, Rottoli P, Coviello G, Perari MG, Galeazzi M, Vagliasindi M. Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease. Clin Rheumatol 1997; 16: 570-7
  8. Park JH, Kim DS, Park I, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-11
  9. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90
  10. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4
  11. Reveille JD, Solomon DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003; 49: 399-412
  12. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437-44
  13. Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, et al; Scleroderma Lung Study Research Group. Bronchoalveolar lavage and response to cyclo